LLY

920.66

+0.74%↑

UNH

591.96

+1.78%↑

NVO

117.12

-0.12%↓

JNJ

160.83

+0.76%↑

ABBV

194.81

+0.93%↑

LLY

920.66

+0.74%↑

UNH

591.96

+1.78%↑

NVO

117.12

-0.12%↓

JNJ

160.83

+0.76%↑

ABBV

194.81

+0.93%↑

LLY

920.66

+0.74%↑

UNH

591.96

+1.78%↑

NVO

117.12

-0.12%↓

JNJ

160.83

+0.76%↑

ABBV

194.81

+0.93%↑

LLY

920.66

+0.74%↑

UNH

591.96

+1.78%↑

NVO

117.12

-0.12%↓

JNJ

160.83

+0.76%↑

ABBV

194.81

+0.93%↑

LLY

920.66

+0.74%↑

UNH

591.96

+1.78%↑

NVO

117.12

-0.12%↓

JNJ

160.83

+0.76%↑

ABBV

194.81

+0.93%↑

Начало・Списък с акции・Cara Therapeutics Inc

Cara Therapeutics Inc

Отворен

Сектор Здравеопазване

0.25

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.25

Максимум

0.25

Ключови измерители
By Trading Economics
Продажби	3M
EPS	-0.59
Служители	55

Дивиденти
By Dow Jones
Следващи печалби	11.11.2024 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-2.3M 46M
Предишно отваряне	0.25
Предишно затваряне	0.25

Настроения в новините

By Acuity

50%

173 / 366 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

0.257 / 0.3148 Подкрепа & съпротива

Cara Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

8.10.2024 г., 23:44 ч. UTC

Топ новини

Печалби

GM Met With Investors Tuesday. The Car Business Is Better Than Many Fear. -- Barrons.com

8.10.2024 г., 23:12 ч. UTC

Придобивния, сливания и поглъщания

Woodside Completes Acquisition Of Tellurian >WDS.AU

8.10.2024 г., 23:03 ч. UTC

Топ новини

Federal Deficit Hit $1.8 Trillion for 2024, CBO Say -- 5th Update

8.10.2024 г., 22:57 ч. UTC

Топ новини

Federal Deficit Hit $1.8 Trillion for 2024, CBO Say -- 4th Update

8.10.2024 г., 22:54 ч. UTC

Пазарно говорене

Печалби

PepsiCo's Promotional Approach at Core of Debate -- Market Talk

8.10.2024 г., 22:38 ч. UTC

Придобивния, сливания и поглъщания

Paladin: No Certainty Paladin Will Be Able to Obtain Investment Canada Act Clearance for Fission Uranium Deal

8.10.2024 г., 22:37 ч. UTC

Придобивния, сливания и поглъщания

Paladin: Fission Uranium Acquisition Is Under National Security Review

8.10.2024 г., 22:37 ч. UTC

Придобивния, сливания и поглъщания

Paladin: Fission Uranium Acquisition Still Requires Clearance Under Investment Canada Act

8.10.2024 г., 22:36 ч. UTC

Придобивния, сливания и поглъщания

Paladin: Canadian Court Approves Acquisition of Fission Uranium

8.10.2024 г., 22:34 ч. UTC

Пазарно говорене

Pro Medicus Doing Well But Some Concerns Remain -- Market Talk

8.10.2024 г., 22:28 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

8.10.2024 г., 22:28 ч. UTC

Пазарно говорене

Infratil's CDC Valuation Could Be Conservative -- Market Talk

8.10.2024 г., 22:08 ч. UTC

Придобивния, сливания и поглъщания

Woodside Says Driftwood LNG Project Renamed Woodside Louisiana LNG

8.10.2024 г., 22:08 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy Completes Acquisition of Tellurian

8.10.2024 г., 21:42 ч. UTC

Топ новини

Federal Deficit Hit $1.8 Trillion for 2024, CBO Say -- 3rd Update

8.10.2024 г., 21:26 ч. UTC

Топ новини

Hurricane Milton Might Distort Economic Data. GDP Could Take a Hit. -- Barrons.com

8.10.2024 г., 21:17 ч. UTC

Топ новини

GM Met With Investors Tuesday. The Car Business Is Better Than Many Fear. -- Barrons.com

8.10.2024 г., 21:00 ч. UTC

Пазарно говорене

ESG Roundup: Market Talk

8.10.2024 г., 20:54 ч. UTC

Топ новини

Fed's Collins Sees More Rate Cuts Ahead to Freeze the Economy Where It Is Now -- Barrons.com

8.10.2024 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

8.10.2024 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

8.10.2024 г., 20:18 ч. UTC

Топ новини

S&P Gains; Tumult Grips Chinese Stocks -- WSJ

8.10.2024 г., 20:00 ч. UTC

Топ новини

Federal Deficit Hit $1.8 Trillion for 2024, CBO Say -- 2nd Update

8.10.2024 г., 19:35 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

8.10.2024 г., 19:07 ч. UTC

Пазарно говорене

Oil Futures Give Back Gains as Risk of Supply Disruption Eases -- Market Talk

8.10.2024 г., 18:43 ч. UTC

Топ новини

Fed's Bostic Eyes Hurricane Fallout as Economic Risks Remain Balanced -- Barrons.com

8.10.2024 г., 18:42 ч. UTC

Топ новини

Federal Deficit Hit $1.8 Trillion for 2024, CBO Says -- Update

8.10.2024 г., 18:31 ч. UTC

Печалби

GM Stock Rises After Management Provides Some Insight Into 2025 -- Barrons.com

8.10.2024 г., 18:29 ч. UTC

Печалби

Hot Research: 6 Stocks That Can Pop in a So-So Earnings Season -- Barrons.com

8.10.2024 г., 18:28 ч. UTC

Печалби

Decision Time for GM in China: Stay, Scale Back or Go -- Update

Сравнение с други в отрасъла

Ценова промяна

Cara Therapeutics Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Cara Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

0.257 / 0.3148Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

There are no events.

Настроение

By Acuity

173 / 366 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Cara Therapeutics Inc

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). The Company is developing a class of product candidates KORSUVA (CR845/difelikefalin), which is a KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. The Company is also conducting preclinical studies and clinical trials of CR845/difelikefalin-based product candidates.